Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2023-03-14 00:00:00 ET · period of report 2023-03-10 · accession 0001209191-23-018460 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-03-14 | 2023-03-10+ | VRTX | WAGNER CHARLES F JR | EVP, CFO | S - Sale | $291.98 | -4,754 | 56.9K | -8% | -$1.39M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-10 | S | D | 185 | $292.68 | 56,174 | D | — | — | (F2) Mr. Wagner undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F7) Open market sales reported on this line occurred at a weighted average price of $292.68 (range $292.14 to $293.12). |
| 2 | Common | Common Stock | 2023-03-13 | S | D | 62 | $296.77 | 53,379 | D | — | — | |
| 3 | Common | Common Stock | 2023-03-13 | S | D | 292 | $295.89 | 53,441 | D | — | — | (F2) Mr. Wagner undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F12) Open market sales reported on this line occurred at a weighted average price of $295.89 (range $295.33 to $296.32). |
| 4 | Common | Common Stock | 2023-03-13 | S | D | 715 | $294.52 | 53,733 | D | — | — | (F2) Mr. Wagner undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F11) Open market sales reported on this line occurred at a weighted average price of $294.52 (range $294.13 to $294.81). |
| 5 | Common | Common Stock | 2023-03-13 | S | D | 1,153 | $293.35 | 54,448 | D | — | — | (F10) Open market sales reported on this line occurred at a weighted average price of $293.35 (range $292.99 to $293.80). (F2) Mr. Wagner undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| 6 | Common | Common Stock | 2023-03-13 | S | D | 420 | $292.41 | 55,061 | D | — | — | (F2) Mr. Wagner undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F9) Open market sales reported on this line occurred at a weighted average price of $292.41 (range $291.97 to $292.82). |
| 7 | Common | Common Stock | 2023-03-13 | S | D | 24 | $288.31 | 56,021 | D | — | — | |
| 8 | Common | Common Stock | 2023-03-10 | S | D | 102 | $294.94 | 56,045 | D | — | — | (F2) Mr. Wagner undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F8) Open market sales reported on this line occurred at a weighted average price of $294.94 (range $294.85 to $295.35). |
| 9 | Common | Common Stock | 2023-03-10 | S | D | 27 | $293.61 | 56,147 | D | — | — | |
| 10 | Common | Common Stock | 2023-03-10 | S | D | 541 | $291.47 | 56,359 | D | — | — | (F6) Open market sales reported on this line occurred at a weighted average price of $291.47 (range $291.10 to $292.00). (F2) Mr. Wagner undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| 11 | Common | Common Stock | 2023-03-10 | S | D | 30 | $289.44 | 56,900 | D | — | — | |
| 12 | Common | Common Stock | 2023-03-10 | S | D | 361 | $286.64 | 57,772 | D | — | — | (F3) Open market sales reported on this line occurred at a weighted average price of $286.64 (range $286.17 to $287.16). (F2) Mr. Wagner undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| 13 | Common | Common Stock | 2023-03-10 | S | D | 515 | $287.83 | 57,257 | D | — | — | (F2) Mr. Wagner undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F4) Open market sales reported on this line occurred at a weighted average price of $287.83 (range $287.30 to $288.20). |
| 14 | Common | Common Stock | 2023-03-10 | S | D | 327 | $288.91 | 56,930 | D | — | — | (F2) Mr. Wagner undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F5) Open market sales reported on this line occurred at a weighted average price of $288.91 (range $288.37 to $289.34). |